Abstract
Despite the well-known role of obesity as risk factor for Juvenile Idiopathic Arthritis (JIA) severity, emerging but limited evidence suggested a similar role for underweight. We investigated the role of body mass index (BMI) across its full spectrum in a cohort of children with JIA.
We retrospectively studied 113 children with JIA classified according to the International League of Association for Rheumatology (ILAR) criteria attending our Rheumatology Clinic. The patients underwent a comprehensive evaluation including both clinical and biochemical assessments. According to BMI Z-score, the cohort was divided into five groups as underweight, normal weight, overweight (OW), obesity (OB), and severe OB. Disease activity was calculated by Juvenile Arthritis Disease Activity Score 10 (JADAS-10) joint reduced count and relapses were defined according to Wallace criteria.
The mean age of the cohort was 7.43 ± 4.03 years. The prevalence of underweight, normal weight, OW, OB, and severe OB was 7.2%, 54.1%, 10.8%, 17.1%, and 10.8%, respectively. Significant higher ferritin levels and erythrocyte sedimentation rate values were found in patients with severe OB and underweight compared to subjects belonging to normal weight, OW, and OB groups. A greater JADAS-10 score was observed in underweight patients and in those with severe OB than other groups. The relapse rate was higher in patients with severe OB and underweight compared to other groups.
Conclusions: Both underweight and OB might negatively affect JIA course. Weight control is fundamental in children with JIA to avoid a more unfavourable course of the disease.
What is Known: • Obesity represents a well-known risk factor for JIA severity. • The role of underweight in children with JIA is still poorly explored. | |
What is New: • As observed in children with obesity, underweight young patients with JIA seem to experience a more severe JIA course. • Healthy lifestyle promotion in children with JIA is a crucial step in the management of the disease. |
Similar content being viewed by others
Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
Abbreviations
- BMI:
-
Body mass index
- DMARDs:
-
Disease-modifying anti-rheumatic drugs
- ILAR:
-
International League of Association for Rheumatology
- JIA:
-
Juvenile Idiopathic Arthritis
- JADAS-10:
-
Juvenile Arthritis Disease Activity Score 10
- NSAIDs:
-
Non-steroidal anti-inflammatory drugs
- OB:
-
Obesity
- OW:
-
Overweight
- RA:
-
Rheumatoid arthritis
References
Ravelli A, Martini A (2007) Juvenile idiopathic arthritis. Lancet 369:767–778
Gicchino MF, Marzuillo P, Zarrilli S, Melone R, Guarino S, Miraglia Del Giudice E, Olivieri AN, Di Sessa A (2023) Uric acid could be a marker of cardiometabolic risk and disease severity in children with juvenile idiopathic arthritis. Eur J Pediatr 182:149–154
Sule S, Fontaine K (2018) Metabolic syndrome in adults with a history of juvenile arthritis. Open Access Rheumatol 10:67–72
Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, He X, Maldonado-Cocco J, Orozco-Alcala J, Prieur AM, Suarez-Almazor ME, Woo P (2004) International League of Associations for R: International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:390–392
Mannion ML, Cron RQ (2022) Therapeutic strategies for treating juvenile idiopathic arthritis. Curr Opin Pharmacol 64:102226
Ringold S, Weiss PF, Beukelman T, DeWitt EM, Ilowite NT, Kimura Y, Laxer RM, Lovell DJ, Nigrovic PA, Robinson AB, Vehe RK (2013) American Collge of R: 2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications. Arthritis Rheum 65:2499–2512
Beukelman T, Patkar NM, Saag KG, Tolleson-Rinehart S, Cron RQ, DeWitt EM, Ilowite NT, Kimura Y, Laxer RM, Lovell DJ, Martini A, Rabinovich CE, Ruperto N (2011) 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res (Hoboken) 63:465–482
Giani T, De Masi S, Maccora I, Tirelli F, Simonini G, Falconi M, Cimaz R (2019) The influence of overweight and obesity on treatment response in juvenile idiopathic arthritis. Front Pharmacol 10:637
Neto A, Mourao AF, Oliveira-Ramos F, Campanilho-Marques R, Estanqueiro P, Salgado M, Guedes M, Piotto D, Emi Aikawa N, Melo Gomes J, Cabral M, Conde M, Figueira R, Santos MJ, Fonseca JE, Terreri MT, Canhao H (2021) Association of body mass index with Juvenile Idiopathic Arthritis disease activity: a Portuguese and Brazilian collaborative analysis. Acta Reumatol Port 46:7–14
Guzman J, Kerr T, Ward LM, Ma J, Oen K, Rosenberg AM, Feldman BM, Boire G, Houghton K, Dancey P, Scuccimarri R, Bruns A, Huber AM, Watanabe Duffy K, Shiff NJ, Berard RA, Levy DM, Stringer E, Morishita K, Johnson N, Cabral DA, Larche M, Petty RE, Laxer RM, Silverman E, Miettunen P, Chetaille AL, Haddad E, Spiegel L, Turvey SE, Schmeling H, Lang B, Ellsworth J, Ramsey SE, Roth J, Campillo S, Benseler S, Chedeville G, Schneider R, Tse SML, Bolaria R, Gross K, Feldman D, Cameron B, Jurencak R, Dorval J, LeBlanc C, St Cyr C, Gibbon M, Yeung RSM, Duffy CM, Tucker LB (2017) Growth and weight gain in children with juvenile idiopathic arthritis: results from the ReACCh-Out cohort. Pediatr Rheumatol Online J 15:68
Caetano MC, Sarni RO, Terreri MT, Ortiz TT, Pinheiro M, de Souza FI, Hilario MO (2012) Excess of adiposity in female children and adolescents with juvenile idiopathic arthritis. Clin Rheumatol 31:967–971
Held M, Sestan M, Jelusic M (2022) Obesity as a comorbidity in children and adolescents with autoimmune rheumatic diseases. Rheumatol Int
Kreps DJ, Halperin F, Desai SP, Zhang ZZ, Losina E, Olson AT, Karlson EW, Bermas BL, Sparks JA (2018) Association of weight loss with improved disease activity in patients with rheumatoid arthritis: a retrospective analysis using electronic medical record data. Int J Clin Rheumtol 13:1–10
Vennu V, Alenazi AM, Abdulrahman TA, Binnasser AS, Bindawas SM (2020) Obesity and multisite pain in the lower limbs: data from the osteoarthritis initiative. Pain Res Manag 2020:6263505
Ravelli A, Consolaro A, Horneff G, Laxer RM, Lovell DJ, Wulffraat NM, Akikusa JD, Al-Mayouf SM, Anton J, Avcin T, Berard RA, Beresford MW, Burgos-Vargas R, Cimaz R, De Benedetti F, Demirkaya E, Foell D, Itoh Y, Lahdenne P, Morgan EM, Quartier P, Ruperto N, Russo R, Saad-Magalhaes C, Sawhney S, Scott C, Shenoi S, Swart JF, Uziel Y, Vastert SJ, Smolen JS (2018) Treating juvenile idiopathic arthritis to target: recommendations of an international task force. Ann Rheum Dis 77:819–828
Wallace CA, Ruperto N, Giannini E, Childhood A, Rheumatology Research A (2004) Pediatric Rheumatology International Trials O, Pediatric Rheumatology Collaborative Study G: preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol 31:2290–2294
Freedman DS, Berenson GS (2017) Tracking of BMI z scores for severe obesity. Pediatrics 140
de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J (2007) Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ 85:660–667
Merwin S, Mackey E, Sule S (2021) US NHANES Data 2013–2016: increased risk of severe obesity in individuals with history of juvenile idiopathic arthritis. Pediatr Rheumatol Online J 19:119
Diaz-Cordoves Rego G, Nunez-Cuadros E, Mena-Vazquez N, Aguado Henche S, Galindo-Zavala R, Manrique-Arija S, Martin-Pedraz L, Redondo-Rodriguez R, Godoy-Navarrete FJ, Fernandez-Nebro A (2021) Adiposity is related to inflammatory disease activity in Juvenile Idiopathic Arthritis. J Clin Med 10
Schulert GS, Graham TB (2014) Chronic inflammatory arthritis of the ankle/hindfoot/midfoot complex in children with extreme obesity. J Clin Rheumatol 20:317–321
Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB (2001) Low-grade systemic inflammation in overweight children. Pediatrics 107:E13
Sandstedt E, Fasth A, Eek MN, Beckung E (2013) Muscle strength, physical fitness and well-being in children and adolescents with juvenile idiopathic arthritis and the effect of an exercise programme: a randomized controlled trial. Pediatr Rheumatol Online J 11:7
MacDonald IJ, Liu SC, Huang CC, Kuo SJ, Tsai CH, Tang CH (2019) Associations between adipokines in arthritic disease and implications for obesity. Int J Mol Sci 20
Derdemezis CS, Voulgari PV, Drosos AA, Kiortsis DN (2011) Obesity, adipose tissue and rheumatoid arthritis: coincidence or more complex relationship? Clin Exp Rheumatol 29:712–727
Halle M, Korsten-Reck U, Wolfarth B, Berg A (2004) Low-grade systemic inflammation in overweight children: impact of physical fitness. Exerc Immunol Rev 10:66–74
Tam CS, Clement K, Baur LA, Tordjman J (2010) Obesity and low-grade inflammation: a paediatric perspective. Obes Rev 11:118–126
Stavropoulos-Kalinoglou A, Metsios GS, Panoulas VF, Nevill AM, Jamurtas AZ, Koutedakis Y, Kitas GD (2009) Underweight and obese states both associate with worse disease activity and physical function in patients with established rheumatoid arthritis. Clin Rheumatol 28:439–444
Bout-Tabaku S (2018) General nutrition and fitness for the child with rheumatic disease. Pediatr Clin North Am 65:855–866
Acknowledgements
The authors are grateful to all patients and their families.
Author information
Authors and Affiliations
Contributions
MFG and ADS drafted the paper. EMDG, ANO, and ADS participated in the conception and the design of the study. SZ, RM, and PM examined the patients and collected anthropometric and biochemical data. ADS, MFG, and PM performed data analysis. ADS, EMDG, ANO, and PM supervised the design and execution of the study. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the Research Ethical Committee of University of Campania “Luigi Vanvitelli” (protocol code 834/2016).
Consent to participate
Informed consent was obtained from all individual participants included in the study. Patients’ data were treated to guarantee confidentiality.
Competing interest
The authors declare no competing interests.
Additional information
Communicated by Peter de Winter
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Gicchino, M., Marzuillo, P., Melone, R. et al. The dual role of body mass index on Juvenile Idiopathic Arthritis course: a pediatric experience. Eur J Pediatr 183, 809–813 (2024). https://doi.org/10.1007/s00431-023-05348-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-023-05348-8